Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
These changes will affect fully insured large group commercial members, with a significant shift coming on January 1, 2025, when coverage for these medications will be discontinued altogether
Diffusivity measurements differentiate benign from malignant lesions in patients with peripheral neuropathy or plexopathy
These documents include analytical data such as HPLC chromatograms and mass spectrometry results to verify identity and purity
The refund policy (membership fees nonrefundable, no refunds during commitment, no refunds for unused services) is buried
US$ 23.37
US$ 24.88
US$ 26.00
US$ 24.83
US$ 25.80
